Lead sponsor
Ono Pharmaceutical Co., Ltd.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
2
Ongoing
330
Total enrollment
131
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Trials by status
Recruiting
1
Active, not recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 2Active, not recruiting240
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease DementiaAlzheimer's diseasePh 2Recruiting90